Polyganics BV - Product Pipeline Analysis, 2019 Update
- GDME13577PD
- Slides: 35
- June 2019
- Total Views:1209
- Region : Europe
- GlobalData
- Equity Research Report
About the Report
About the Report
Summary
Polyganics BV (Polyganics) is a medical technology company that develops, manufactures and commercializes bioresorbable medical devices which facilitate tissue repair and regeneration. The company provides a range of products for ear, nose and throat (ENT) procedures; peripheral nerve repair (PNR) and neurosurgery; and general surgery. Its proprietary polymer technology platforms allow the creation of bioresorbable synthetic polymers for different clinical applications that improve surgical outcomes such as hemostatic control, drug elution, tissue regeneration, and others. Polyganics works in collaboration with other medical technology companies and academic centers for in-licensing and co-development of bioresorbable devices. The company distributes its products across China, Australia, India, France, Brazil, Argentina, Mexico, Malaysia, Vietnam, Germany and the US, among others. Polyganics is headquartered in Groningen, the Netherlands.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Polyganics BV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Polyganics BV, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Rovers Medical Devices B.V.
Omron Healthcare Europe BV
Elana bv
Curan Medical B.V.
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Polyganics BV Company Overview
Polyganics BV Company Snapshot
Polyganics BV Pipeline Products and Ongoing Clinical Trials Overview
Polyganics BV-Pipeline Analysis Overview
Polyganics BV-Key Facts
Polyganics BV-Major Products and Services
Polyganics BV Pipeline Products by Development Stage
Polyganics BV Ongoing Clinical Trials by Trial Status
Polyganics BV Pipeline Products Overview
3D Printed Scaffold
3D Printed Scaffold Product Overview
Drug Eluting Device
Drug Eluting Device Product Overview
LIQOSEAL-Dura Sealing Patch
LIQOSEAL-Dura Sealing Patch Product Overview
LIQOSEAL-Dura Sealing Patch Clinical Trial
LIQOSEAL-Spine Application
LIQOSEAL-Spine Application Product Overview
Liver and Pancreas Sealing Patch-Adjacent Indications
Liver and Pancreas Sealing Patch-Adjacent Indications Product Overview
Liver and Pancreas Sealing Patch-HPB Surgery
Liver and Pancreas Sealing Patch-HPB Surgery Product Overview
Neurolac Wrap
Neurolac Wrap Product Overview
Surgical Mesh
Surgical Mesh Product Overview
Polyganics BV-Key Competitors
Polyganics BV-Key Employees
Polyganics BV-Locations And Subsidiaries
Head Office
Recent Developments
Polyganics BV, Recent Developments
Apr 10, 2019: Polyganics builds new facility to continue growth, supported by RIG subsidy of EUR3.8 Million
Oct 22, 2018: Polyganics initiates first-in-human trial of LIQOSEAL,its innovative approach for dural closure
Sep 10, 2018: Polyganics strengthens global distribution network with appointment of Synovis MCA as US-wide distributor of NEUROCAP
Mar 08, 2018: FDA Grants Breakthrough Device Designation to Polyganics' Liver and Pancreas Sealant Patch
Dec 01, 2017: Polyganics awarded EUR1.2 million to complete clinical development of dura sealant patch
Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors
Jun 08, 2017: Polyganics signs up multiple distributors in Europe to accelerate roll-out of Peripheral Nerve Repair portfolio
Apr 20, 2017: Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study
Feb 16, 2017: Polyganics' STOP NEUROMA Study Interim Data Shows Reduction in Pain
Dec 07, 2016: Polyganics announces Birmingham Hand Centre efficacy study of nerve conduit NEUROLAC in finger surgery
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Polyganics BV Pipeline Products by Equipment Type
Polyganics BV Pipeline Products by Development Stage
Polyganics BV Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
Polyganics BV Pipeline Products and Ongoing Clinical Trials Overview
Polyganics BV Pipeline Products by Equipment Type
Polyganics BV Pipeline Products by Indication
Polyganics BV Ongoing Clinical Trials by Trial Status
Polyganics BV, Key Facts
Polyganics BV, Major Products and Services
Polyganics BV Number of Pipeline Products by Development Stage
Polyganics BV Pipeline Products Summary by Development Stage
Polyganics BV Ongoing Clinical Trials by Trial Status
Polyganics BV Ongoing Clinical Trials Summary
3D Printed Scaffold-Product Status
3D Printed Scaffold-Product Description
Drug Eluting Device-Product Status
Drug Eluting Device-Product Description
LIQOSEAL-Dura Sealing Patch-Product Status
LIQOSEAL-Dura Sealing Patch-Product Description
LIQOSEAL-Dura Sealing Patch-Single-arm, Open-label, Multicenter Study to Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
LIQOSEAL-Spine Application-Product Status
LIQOSEAL-Spine Application-Product Description
Liver and Pancreas Sealing Patch-Adjacent Indications-Product Status
Liver and Pancreas Sealing Patch-Adjacent Indications-Product Description
Liver and Pancreas Sealing Patch-HPB Surgery-Product Status
Liver and Pancreas Sealing Patch-HPB Surgery-Product Description
Neurolac Wrap-Product Status
Neurolac Wrap-Product Description
Surgical Mesh-Product Status
Surgical Mesh-Product Description
Polyganics BV, Key Employees
Glossary
Why Buy From US?

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
Why Client Choose Us?
Trusted By 2500+ Brands




.png)
.svg.png)













.png)
.svg.png)








